Filing Details
- Accession Number:
- 0001179110-19-002928
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-01 17:12:06
- Reporting Period:
- 2019-02-28
- Accepted Time:
- 2019-03-01 17:12:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 720154 | Bioanalytical Systems Inc | BASI | Services-Commercial Physical & Biological Research (8731) | 351345024 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1762245 | Jr. Robert Leasure | C/O Bioanalytical Systems, Inc. 2701 Kent Avenue West Lafayette IN 47906-1382 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Acquisiton | 2019-02-28 | 8,900 | $1.51 | 79,615 | No | 4 | P | Direct | |
| Common Shares | Acquisiton | 2019-03-01 | 10,000 | $1.62 | 89,615 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.49 to $1.55, inclusive. The reporting person undertakes to provide to Bioanalytical Systems, Inc., any security holder of Bioanalytical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.56 to $1.65, inclusive. The reporting person undertakes to provide to Bioanalytical Systems, Inc., any security holder of Bioanalytical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
